BostonGene Tumor Portrait™ Tests
BostonGene Tumor Portrait™ Tests, based on integrated genomic and transcriptomic analysis, propel precision medicine into daily clinical practice and supports physicians in actualizing personalized therapy for cancer patients.
BostonGene integrated genomic and transcriptomic analysis, in concert with the patient’s clinical history, provides information regarding the likely benefits of therapies or therapeutic combinations, suitable NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines®) treatment recommendations and ongoing clinical trials.
The BostonGene Tumor Portrait™ test combines precise data-processing and proprietary algorithms to generate easy-to-understand tumor schematics, the Molecular Functional Portrait™ (Cancer Cell, 2021 Jun 14;39(6):845-865.e7).
The BostonGene Tumor Portrait™ test directly depicts tumor cellular composition, microenvironment composition, immune activity, and other tumor activating or suppressing processes. BostonGene integrated model of tumor genetics, transcriptomics, microenvironment and tumor composition provides a 360° overview of a patient tumor to give medical professionals invaluable insights into potential treatment options.
HOW TO START
BostonGene works directly with oncologists, care teams, surgeons and pathologists to assist with every step of the process from test request placement to request delivery. We provide kits that include everything you need for specimen collection and shipping.
Please contact us to learn more about BostonGene tests, order kits or obtain information about clinical trial solutions.
SAMPLE REQUIREMENTS
BostonGene requires normal (blood or saliva) and tumor specimens accepting Formalin-Fixed Paraffin-Embedded (FFPE) or fresh/fresh frozen (FF) tissue.
BOSTONGENE CAP/CLIA LABORATORY
Analysis are performed in the BostonGene Laboratory that is certified under the Clinical Laboratory Improvement Amendments (CLIA) and accredited by the College of American Pathologists (CAP) as qualified to perform high complexity clinical laboratory testing.
SOLID CANCERS
Adrenocortical Cancer
Breast Cancer
Cervical Cancer
Cutaneous Melanoma
CNS Cancer
Colorectal Cancer
Esophageal Cancer
Endometrial Cancer
Glioblastoma
Gastric Cancer
Head and Neck Cancer
Kidney Cancer
Liver Cancer
NSCLC
Ovarian Cancer
Pancreatic Cancer
Prostate Cancer
Sarcomas
Rare Cancers
Thyroid Cancer
Urothelial and Bladder Cancer
Unknown Origin Cancers
HEMATOLOGIC CANCERS
Acute Myeloid Leukemia
Chronic Lymphocytic Leukemia
Diffuse Large B-Cell Lymphoma
Follicular Lymphoma
High-Grade Lymphoma
Mantle Cell Lymphoma
Multiple Myeloma
Peripheral T-Cell Lymphoma